These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

323 related articles for article (PubMed ID: 22797745)

  • 1. Voluntary medical male circumcision: an HIV prevention priority for PEPFAR.
    Reed JB; Njeuhmeli E; Thomas AG; Bacon MC; Bailey R; Cherutich P; Curran K; Dickson K; Farley T; Hankins C; Hatzold K; Justman J; Mwandi Z; Nkinsi L; Ridzon R; Ryan C; Bock N
    J Acquir Immune Defic Syndr; 2012 Aug; 60 Suppl 3(0 3):S88-95. PubMed ID: 22797745
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Estimating the impact of the US President's Emergency Plan for AIDS Relief on HIV treatment and prevention programmes in Africa.
    Heaton LM; Bouey PD; Fu J; Stover J; Fowler TB; Lyerla R; Mahy M
    Sex Transm Infect; 2015 Dec; 91(8):615-20. PubMed ID: 26056389
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Progress, challenges, and new opportunities for the prevention of mother-to-child transmission of HIV under the US President's Emergency Plan for AIDS Relief.
    Chi BH; Adler MR; Bolu O; Mbori-Ngacha D; Ekouevi DK; Gieselman A; Chipato T; Luo C; Phelps BR; McClure C; Mofenson LM; Stringer JS
    J Acquir Immune Defic Syndr; 2012 Aug; 60 Suppl 3(Suppl 3):S78-87. PubMed ID: 22797744
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Beyond indicators: advances in global HIV monitoring and evaluation during the PEPFAR era.
    Porter LE; Bouey PD; Curtis S; Hochgesang M; Idele P; Jefferson B; Lemma W; Myrick R; Nuwagaba-Biribonwoha H; Prybylski D; Souteyrand Y; Tulli T
    J Acquir Immune Defic Syndr; 2012 Aug; 60 Suppl 3():S120-6. PubMed ID: 22797733
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Scale-up of HIV treatment through PEPFAR: a historic public health achievement.
    El-Sadr WM; Holmes CB; Mugyenyi P; Thirumurthy H; Ellerbrock T; Ferris R; Sanne I; Asiimwe A; Hirnschall G; Nkambule RN; Stabinski L; Affrunti M; Teasdale C; Zulu I; Whiteside A
    J Acquir Immune Defic Syndr; 2012 Aug; 60 Suppl 3(Suppl 3):S96-104. PubMed ID: 22797746
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PEPFAR's evolving HIV prevention approaches for key populations--people who inject drugs, men who have sex with men, and sex workers: progress, challenges, and opportunities.
    Needle R; Fu J; Beyrer C; Loo V; Abdul-Quader AS; McIntyre JA; Li Z; Mbwambo JK; Muthui M; Pick B
    J Acquir Immune Defic Syndr; 2012 Aug; 60 Suppl 3():S145-51. PubMed ID: 22797736
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The expanding role of civil society in the global HIV/AIDS response: what has the President's Emergency Program For AIDS Relief's role been?
    Coutinho A; Roxo U; Epino H; Muganzi A; Dorward E; Pick B
    J Acquir Immune Defic Syndr; 2012 Aug; 60 Suppl 3():S152-7. PubMed ID: 22797737
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Voluntary medical male circumcision: modeling the impact and cost of expanding male circumcision for HIV prevention in eastern and southern Africa.
    Njeuhmeli E; Forsythe S; Reed J; Opuni M; Bollinger L; Heard N; Castor D; Stover J; Farley T; Menon V; Hankins C
    PLoS Med; 2011 Nov; 8(11):e1001132. PubMed ID: 22140367
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PEPFAR, health system strengthening, and promoting sustainability and country ownership.
    Palen J; El-Sadr W; Phoya A; Imtiaz R; Einterz R; Quain E; Blandford J; Bouey P; Lion A
    J Acquir Immune Defic Syndr; 2012 Aug; 60 Suppl 3():S113-9. PubMed ID: 22797732
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PEPFAR scale-up of pediatric HIV services: innovations, achievements, and challenges.
    Abrams EJ; Simonds RJ; Modi S; Rivadeneira E; Vaz P; Kankasa C; Tindyebwa D; Phelps BR; Bowsky S; Teasdale CA; Koumans E; Ruff AJ
    J Acquir Immune Defic Syndr; 2012 Aug; 60 Suppl 3(Suppl 3):S105-12. PubMed ID: 22797731
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effectiveness of Voluntary Medical Male Circumcision for Human Immunodeficiency Virus Prevention in Rakai, Uganda.
    Loevinsohn G; Kigozi G; Kagaayi J; Wawer MJ; Nalugoda F; Chang LW; Quinn TC; Serwadda D; Reynolds SJ; Nelson L; Mills L; Alamo S; Nakigozi G; Kabuye G; Ssekubugu R; Tobian AAR; Gray RH; Grabowski MK;
    Clin Infect Dis; 2021 Oct; 73(7):e1946-e1953. PubMed ID: 33043978
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Voluntary medical male circumcision for HIV prevention among adolescents in Kenya: Unintended consequences of pursuing service-delivery targets.
    Gilbertson A; Ongili B; Odongo FS; Hallfors DD; Rennie S; Kwaro D; Luseno WK
    PLoS One; 2019; 14(11):e0224548. PubMed ID: 31682626
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Voluntary medical male circumcision - southern and eastern Africa, 2010-2012.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2013 Nov; 62(47):953-7. PubMed ID: 24280914
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevention of sexually transmitted HIV infections through the President's Emergency Plan for AIDS Relief: a history of achievements and lessons learned.
    Ryan CA; Conly SR; Stanton DL; Hasen NS
    J Acquir Immune Defic Syndr; 2012 Aug; 60 Suppl 3():S70-7. PubMed ID: 22797743
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Achieving the HIV prevention impact of voluntary medical male circumcision: lessons and challenges for managing programs.
    Sgaier SK; Reed JB; Thomas A; Njeuhmeli E
    PLoS Med; 2014 May; 11(5):e1001641. PubMed ID: 24800840
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Progress in voluntary medical male circumcision for HIV prevention supported by the US President's Emergency Plan for AIDS Relief through 2017: longitudinal and recent cross-sectional programme data.
    Davis SM; Hines JZ; Habel M; Grund JM; Ridzon R; Baack B; Davitte J; Thomas A; Kiggundu V; Bock N; Pordell P; Cooney C; Zaidi I; Toledo C
    BMJ Open; 2018 Sep; 8(8):e021835. PubMed ID: 30173159
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Voluntary medical male circumcision: logistics, commodities, and waste management requirements for scale-up of services.
    Edgil D; Stankard P; Forsythe S; Rech D; Chrouser K; Adamu T; Sakallah S; Thomas AG; Albertini J; Stanton D; Dickson KE; Njeuhmeli E
    PLoS Med; 2011 Nov; 8(11):e1001128. PubMed ID: 22140363
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Scale-Up of Voluntary Medical Male Circumcision Services for HIV Prevention - 12 Countries in Southern and Eastern Africa, 2013-2016.
    Hines JZ; Ntsuape OC; Malaba K; Zegeye T; Serrem K; Odoyo-June E; Nyirenda RK; Msungama W; Nkanaunena K; Come J; Canda M; Nhaguiombe H; Shihepo EK; Zemburuka BLT; Mutandi G; Yoboka E; Mbayiha AH; Maringa H; Bere A; Lawrence JJ; Lija GJI; Simbeye D; Kazaura K; Mwiru RS; Talisuna SA; Lubwama J; Kabuye G; Zulu JE; Chituwo O; Mumba M; Xaba S; Mandisarisa J; Baack BN; Hinkle L; Grund JM; Davis SM; Toledo C
    MMWR Morb Mortal Wkly Rep; 2017 Dec; 66(47):1285-1290. PubMed ID: 29190263
    [TBL] [Abstract][Full Text] [Related]  

  • 19. "What took you so long?" The impact of PEPFAR on the expansion of HIV testing and counseling services in Africa.
    Marum E; Taegtmeyer M; Parekh B; Mugo N; Lembariti S; Phiri M; Moore J; Cheng AS
    J Acquir Immune Defic Syndr; 2012 Aug; 60 Suppl 3():S63-9. PubMed ID: 22797742
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Voluntary medical male circumcision: translating research into the rapid expansion of services in Kenya, 2008-2011.
    Mwandi Z; Murphy A; Reed J; Chesang K; Njeuhmeli E; Agot K; Llewellyn E; Kirui C; Serrem K; Abuya I; Loolpapit M; Mbayaki R; Kiriro N; Cherutich P; Muraguri N; Motoku J; Kioko J; Knight N; Bock N
    PLoS Med; 2011 Nov; 8(11):e1001130. PubMed ID: 22140365
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.